Clinical trial
Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
NCT00250016 · University of New Mexico, Other · Withdrawn
Key facts
| NCT number | NCT00250016 |
|---|---|
| Title | Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) |
| Official title | 1102C-T. Pharmacology Study of Aerosolized Liposomal-Nitro-20 (S)-Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium. Tissue Submission for Patients With Endometrial Cancer. |
| Lead sponsor | University of New Mexico, Other |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Corpus Uteri, Endometrial Cancer |
| Enrollment | 0 |
| Start date | Aug 1, 2003 |
| Primary completion | Apr 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Nov 7, 2005 |
| Last update posted | Dec 14, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: